Financial Reports

Our financial reports are only available in Swedish.

All reports

Calendar

All events

Press releases

All press releases

Subscribe to AcuCort's newsletter

* indicates required

We make good drugs better

AcuCort develops innovative treatments based on existing and well-documented substances in treatment areas where there is a high unmet medical need and commercial interest in new drugs that add benefits such as simplicity of administration.

Read more

Latest videos from AcuCort


Jonas Jönmark, CEO at AcuCort, presents the company at BioStock Life Science Spring Summit 2023. 0:00 Introduction 0:45 Medical need 1:33 Zeqmelit 2:51 Market potential 4:00 Large unmet need: patients and doctors 5:49 Patent and trademark protection 6:21 Commercialisation strategy 7:18 Investment case 8:46 Q&A

YouTube Video VVUyYXc4b2FiRWtRNXJMeUpzdTlVeHhnLnRadmQtMXd1blFR



AcuCort at BioStock Life Science Spring Summit 2023


AcuCort AB


June 1, 2023 08:45


AcuCort sammanfattar höjdpunkterna under Q1 2023.

YouTube Video VVUyYXc4b2FiRWtRNXJMeUpzdTlVeHhnLnJCYVJQS19lWjU4



AcuCort – Q1 2023


AcuCort AB


May 3, 2023 10:38


AcuCorts vd Jonas Jönmark presenterar bolaget på Aktiespararnas

YouTube Video VVUyYXc4b2FiRWtRNXJMeUpzdTlVeHhnLm9rOXh3N3I4TVZj



Acucort – Stora Aktiedagen Stockholm 15 mars 2023


AcuCort AB


March 16, 2023 09:45


AcuCort sammanfattar höjdpunkterna under 2022 och inledningen av 2023.

YouTube Video VVUyYXc4b2FiRWtRNXJMeUpzdTlVeHhnLmFhRzkzSTBTRDdz



AcuCort – Bokslutskommuniké 2022


AcuCort AB


February 24, 2023 10:48